WOMEN'S HEALTH INITIATIVE UPDATE: HT and Venous Thrombosis -- Who's at Greatest Risk?
Women's Health Practice Watch
Subscription Required
In the estrogen-progestin arm of the Women's Health Initiative's hormone therapy trial, 16,608 women were randomly assigned to receive either placebo or conjugated estrogens (0.625 . . .
By Jane E. Corboy, MD
December 28, 2004
Female Physicians Are Changing the Practice of Medicine
Women's Health Practice Watch
Subscription Required
In the U.S., more than 50% of incoming medical students are women, and among practicing physicians, 25% are women. In a recent essay, two female . . .
By Marian C. Limacher, MD
December 8, 2004
Reducing HIV Transmission from Mothers to Newborns
Women's Health Practice Watch
Subscription Required
The recent medical literature has included multiple studies evaluating the effectiveness and consequences of regimens designed to reduce HIV transmission from mothers to their newborns.
By Ann J. Davis, MD
September 21, 2004
Depression: Standardized Treatment Improves Outcomes
Women's Health Practice Watch
Subscription Required
There is a great variety of pharmacologic and psychotherapeutic approaches for treating depression, but clinicians often have insufficient guidance to determine when to change, increase, . . .
By Nada L. Stotland, MD, MPH
September 21, 2004
WOMEN'S HEALTH INITIATIVE UPDATE: Estrogen Therapy Does Not Improve Memory or Prevent Dementia
Women's Health Practice Watch
Subscription Required
The WHI's hormone therapy trial was a randomized, double-blind, placebo-controlled, clinical trial designed to evaluate the effects of estrogen-alone or estrogen-plus-progestin on cardiovascular disease, cancer, . . .
By Jane E. Corboy, MD
September 9, 2004
WOMEN'S HEALTH INITIATIVE UPDATE: Estrogen-Only Arm Stopped
Women's Health Practice Watch
Subscription Required
When the estrogen-progestin arm of the WHI's hormone therapy trial was stopped in 2002 (Journal Watch Women's Health Aug 7 2002 ), the estrogen-only . . .
By Jane E. Corboy, MD
June 9, 2004
Lipophilic Statins May Cause Severe Birth Defects
Women's Health Practice Watch
Subscription Required
In the April 8, 2004, issue of the New England Journal of Medicine , a letter to the editor makes sobering observations about maternal use . . .
By Andrew M. Kaunitz, MD
June 9, 2004
Recommendations for Pregnant Women with WNV Infection
Women's Health Practice Watch
Subscription Required
With summer approaching, the CDC has published interim guidelines for evaluating infants born to women infected with West Nile virus (WNV) during pregnancy.
By Diane E. Judge, APN/CNP
April 20, 2004
WOMEN'S HEALTH INITIATIVE UPDATE: HT and Colorectal Cancer -- Not All Good News
Women's Health Practice Watch
Subscription Required
This is another report from the discontinued, estrogen-progestin arm of the WHI's hormone therapy trial (Journal Watch Women's Health Aug 7 2002 ). In . . .
By Andrew M. Kaunitz, MD
April 20, 2004
Consensus Workshop Proposes New PCOS Diagnostic Criteria
Women's Health Practice Watch
Subscription Required
Polycystic ovary syndrome (PCOS), the leading cause of anovulatory infertility in the U.S., affects 5% to 10% of women of childbearing age. Diagnostic criteria were . . .
By Diane E. Judge, APN/CNP
April 7, 2004
